Entrada Therapeutics
TRDA
#9077
Rank
NZ$0.31 B
Marketcap
NZ$7.95
Share price
-6.25%
Change (1 day)
-55.84%
Change (1 year)

EPS for Entrada Therapeutics (TRDA)

EPS in 2026 (TTM): NZ-$6.72

According to Entrada Therapeutics's latest financial reports the company's current EPS (TTM) is NZ-$7.02. In 2025 the company made an earnings per share (EPS) of NZ-$6.32 a decrease over its 2024 EPS that were of NZ$3.64.

EPS history for Entrada Therapeutics from 2021 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$6.726.27%
2025NZ-$6.32-273.87%
2024NZ$3.64
2022NZ-$5.5231.74%
2021NZ-$4.19